| April 1986 |
Joined Yamanouchi Pharmaceutical Co., Ltd. |
| April 2005 |
Vice President, Project Management, Urology, Astellas Pharma Inc. |
| June 2010 |
Corporate Executive, Astellas Pharma Inc. and Therapeutic Area Head, Urology, Astellas Pharma Europe B.V. |
| October 2010 |
Corporate Executive, Astellas Pharma Inc. and Therapeutic Area Head, Urology, Astellas Pharma Global Development, Inc |
| April 2011 |
Corporate Executive; Vice President, Product & Portfolio Strategy, Astellas Pharma Inc. |
| April 2012 |
Corporate Executive, Chief Strategy Officer (CSTO), Astellas Pharma Inc. |
| June 2012 |
Senior Corporate Executive, Chief Strategy Officer (CSTO), Astellas Pharma Inc. |
| April 2017 |
Senior Corporate Executive, Chief Strategy Officer and Chief Commercial Officer (CSTO & CCO), Astellas Pharma Inc.
|
| June 2017 |
Representative Director, Executive Vice President, Chief Strategy Officer and Chief Commercial Officer (CSTO & CCO), Astellas Pharma Inc. |
| April 2018 |
Representative Director, President, Astellas Pharma Inc. |
| April 2023 |
Representative Director, Chairman of the Board, Astellas Pharma Inc. |
| March 2024 |
Outside Board Director, Resonac Holdings Corporation |